Real-life experience of hepatitis C treatment in a Spanish prison
Rosa Juana Tejera-Pérez(Instituto de Investigación Biomédica de Salamanca), Moncef Belhassen‐García(Universidad de Salamanca), Beatriz Rodríguez-Alonso(University of California, Irvine), María Sánchez Ledesma(Complejo Hospitalario de Salamanca), Alicia Iglesias-Gómez(Instituto de Investigación Biomédica de Salamanca), Juan Luis Muñoz Bellido(Universidad de Salamanca), Antonia Oliva-Oliva(Instituto de Investigación Biomédica de Salamanca), Montserrat Alonso‐Sardón(Universidad de Salamanca), Josué Pendones Ulerio(Universidad de Salamanca), Amparo López‐Bernús(Universidad de Salamanca), Cristina Carbonell(University of California, Irvine)
Cited by 4
Related Papers
Crimean-Congo Hemorrhagic Fever, Spain, 2013–2021
|Emerging infectious diseases|2023|81
<scp>SARS‐CoV</scp>‐2‐reactive antibody detection after <scp>SARS‐CoV</scp>‐2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group
|American Journal of Hematology|2021|64
Predicting Success and Long-Term Outcomes of Percutaneous Mitral Valvuloplasty: A Multifactorial Score
|The American Journal of Medicine|2009|52
Identification of serum endoglin as a novel prognostic marker after acute myocardial infarction
|Journal of Cellular and Molecular Medicine|2008|51